Pathology groups have a much better opportunity to turn the tables on payers and other third parties during contract negotiations if they come armed with the data and other information recommended by two well-respected pathology experts. In this final installment of our four-part series, the price transparency approach is explained. Also discussed is the importance […]
The Role of Price Transparency During Pathology Contract Talks
Also in the March 31, 2025 issue, global IVD companies release their fourth quarter earnings reports
- By Robert Michel
- > From the Volume XXXII, No. 5 - March 31, 2025 Issue
